Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY

Simple item page
dc.contributor.authorPilichiewicz, A.
dc.contributor.authorFeltrin, K.
dc.contributor.authorHorowitz, M.
dc.contributor.authorHoltmann, G.
dc.contributor.authorWishart, J.
dc.contributor.authorJones, K.
dc.contributor.authorTalley, N.
dc.contributor.authorFeinle-Bisset, C.
dc.date.issued2008
dc.description.abstractBACKGROUND/OBJECTIVES: In patients with functional dyspepsia (FD), symptoms are frequently triggered, or exacerbated, by fatty foods. We hypothesized that in FD patients, a high-fat (high-FAT) meal would induce more symptoms than a high-carbohydrate (high-CHO) meal, associated with an altered secretion of cholecystokinin (CCK), peptide-YY (PYY), and ghrelin and an increased antral size, when compared to healthy subjects (HS). METHODS: FD symptoms, appetite perceptions, plasma hormones, and antral area were measured in 8 FD patients and 8 HS on three separate days after the ingestion of high-CHO or high-FAT (500 kcal/400 g) meals, or a low-nutrient control (180 kcal/400 g); the energy intake was quantified 60 min later. RESULTS: Nausea (P < 0.01) and pain (P= 0.05) were greater in FD after the high-FAT, when compared to high-CHO and control meals and in HS. Discomfort was greater after all meals in FD when compared to HS (P < 0.05). Fasting CCK and stimulation of CCK by the high-FAT (P < 0.01) meal were greater in FD, while fasting and postprandial PYY were lower (P < 0.001) in FD than in HS, with no differences in fasting, or postprandial, plasma ghrelin between FD and HS. Fasting antral area was greater in FD (P < 0.05), with no differences postprandially between FD and HS. There were no differences in the energy intake between the two groups. CONCLUSIONS: In FD patients: (a) a high-FAT meal induces more symptoms than an isocaloric high-CHO meal, and (b) fasting and postprandial plasma CCK concentrations are greater and PYY concentrations are less. Our findings have important implications for the development of diet-based therapies for the treatment of FD.
dc.description.statementofresponsibilityAmelia N Pilichiewicz, Kate L. Feltrin, Michael Horowitz, Gerald Holtmann, Judith M. Wishart, Karen L. Jones, Nicholas J. Talley and Christine Feinle-Bisset
dc.identifier.citationAmerican Journal of Gastroenterology, 2008; 103(10):2613-2623
dc.identifier.doi10.1111/j.1572-0241.2008.02041.x
dc.identifier.issn0002-9270
dc.identifier.issn1572-0241
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]
dc.identifier.orcidJones, K. [0000-0002-1155-5816]
dc.identifier.orcidFeinle-Bisset, C. [0000-0001-6848-0125]
dc.identifier.urihttp://hdl.handle.net/2440/50906
dc.language.isoen
dc.publisherBlackwell Publishing Ltd
dc.rights© 2009 The American College of Gastroenterology
dc.source.urihttps://doi.org/10.1111/j.1572-0241.2008.02041.x
dc.subjectHumans
dc.subjectDisease Progression
dc.subjectDyspepsia
dc.subjectCholecystokinin
dc.subjectPeptide YY
dc.subjectDietary Carbohydrates
dc.subjectDietary Fats
dc.subjectPrognosis
dc.subjectFasting
dc.subjectFollow-Up Studies
dc.subjectPostprandial Period
dc.subjectAdult
dc.subjectMiddle Aged
dc.subjectFemale
dc.subjectSurveys and Questionnaires
dc.titleFunctional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications